HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The impact of venetoclax based regimens in the preemptive of measurable residual disease in acute myeloid leukemia.

AuthorsQiuyun Fang, Xiaoyuan Gong, Yan Li, Benfa Gong, Yuntao Liu, Kaiqi Liu, Guangji Zhang, Shuning Wei, Dong Lin, Bingcheng Liu, Ying Wang, Hui Wei, Yingchang Mi, Jianxiang Wang
JournalBlood science (Baltimore, Md.) (Blood Sci) Vol. 4 Issue 1 Pg. 44-46 (Jan 2022) ISSN: 2543-6368 [Electronic] United States
PMID35399543 (Publication Type: Journal Article)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: